Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net loss	$ (4,373,667)	$ (5,613,421)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	27,402	26,365
Stock based compensation	887,607	1,880,150
Warrant repricing expense	0	345,841
Common stock issued for services	33,600	0
Loss on share for warrant exchanges	130,214	0
Loss on debt extinguishment	376,909	558,198
Amortization of debt discount and deferred financing costs	215,376	65,637
Changes in operating assets and liabilities:
Accounts receivable	0	199,471
Prepaid expenses and other current assets	23,014	21,522
Accounts payable and other current liabilities	(219,806)	51,053
Due to related parties	6,600	(86,750)
Net cash used in operating activities	(2,892,751)	(2,551,934)
Cash flows from investing activities:
Purchases of property and equipment	(23,705)	(2,961)
Net cash used in investing activities	(23,705)	(2,961)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net	7,166,081	554,306
Proceeds from the issuance of convertible notes payable, net	0	577,460
Cash paid for repurchase of restricted stock units	(198,527)	(71,993)
Net cash provided by financing activities	6,967,554	1,059,773
Net increase (decrease) in cash	4,051,098	(1,495,122)
Cash at beginning of period	1,559,701	2,123,737
Cash at end of period	5,610,799	628,615
Supplemental disclosures of non-cash investing and financing activities:
Issuance of shares under conversions of convertible notes payable and related accrued interest	362,765	61,766
Issuance of shares under vested restricted stock units	120	33
Recorded debt discount on convertible notes	0	863,868
Issuance of shares under cashless warrant exchanges	0	3
Reclassification of accrued interest to convertible notes payable	$ 0	$ 85,031